01—History
Gross Profit History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2021–FY2025. Drag across the bars to change the range.
- $481.1M
1 older move runs past ±150% (largest +3079.6%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is gross profit?
Gross profit can be defined as revenue minus the cost of goods sold, representing the profit a company makes before deducting operating expenses.
What is BridgeBio Pharma's current gross profit?
BridgeBio Pharma (BBIO) annual gross profit for 2025 was $481.1M, a 120.67% increase from 2024. BridgeBio Pharma gross profit for the quarter ending September 30, 2026 was $332.7M.
What was BridgeBio Pharma's gross profit in 2024?
BridgeBio Pharma annual gross profit for 2024 was $218.0M, a 3079.58% increase from 2023.
What was BridgeBio Pharma's gross profit in 2023?
BridgeBio Pharma annual gross profit for 2023 was $6.9M, a 90.76% decline from 2022.
What is BridgeBio Pharma's 4-year gross profit CAGR?
BridgeBio Pharma gross profit grew at a compound annual growth rate (CAGR) of 63.94% from FY2021 to FY2025, going from $66.6M to $481.1M over 4 years.
- Company
- BridgeBio Pharma
- Ticker
- BBIO
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations